financetom
Business
financetom
/
Business
/
DXC Technology's Fiscal Q1 Non-GAAP Earnings, Revenue Fall; Fiscal Q2 Guidance Issued, 2026 Oulook Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DXC Technology's Fiscal Q1 Non-GAAP Earnings, Revenue Fall; Fiscal Q2 Guidance Issued, 2026 Oulook Raised
Aug 1, 2025 1:14 AM

03:55 AM EDT, 08/01/2025 (MT Newswires) -- DXC Technology ( DXC ) reported fiscal Q1 non-GAAP earnings late Thursday of $0.68 per diluted share, down from $0.75 a year earlier.

Analysts polled by FactSet expected $0.62.

Revenue for the quarter ended June 30 was $3.16 billion, down from $3.24 billion a year earlier.

Analysts surveyed by FactSet expected $3.08 billion.

The company said it expects fiscal Q2 non-GAAP diluted EPS in the range of $0.65 to $0.75 on total revenue of $3.15 billion to $3.18 billion. Analysts polled by FactSet expect $0.71 and $3.14 billion, respectively.

DXC also said it now expects fiscal 2026 non-GAAP diluted EPS in the range of $2.85 to $3.35, up from its prior range of $2.75 to $3.25. Analysts polled by FactSet expect $3.05.

Total revenue for the fiscal year is now expected between $12.61 billion and $12.87 billion, up from its previous range of $12.18 billion to $12.44 billion. Analysts surveyed by FactSet expect $12.61 billion.

DXC's shares were up 4% in recent Thursday after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Serina Therapeutics Raises $5 Million for Clinical Development of Parkinson's Drug
Serina Therapeutics Raises $5 Million for Clinical Development of Parkinson's Drug
Apr 8, 2025
04:45 PM EDT, 04/08/2025 (MT Newswires) -- Serina Therapeutics ( SER ) said Tuesday that it raised $5 million in financing from shareholders, which will be utilized to support the development of POZ-apomorphine to treat Advanced Parkinson's disease. The phase 1 clinical trial of the candidate is expected to commence in Q4, the company said. The company raised the financing...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Cal-Maine Foods Fiscal Q3 Net Income, Sales Rise; Echo Lake Foods Acquisition Set
Cal-Maine Foods Fiscal Q3 Net Income, Sales Rise; Echo Lake Foods Acquisition Set
Apr 8, 2025
04:48 PM EDT, 04/08/2025 (MT Newswires) -- Cal-Maine Foods ( CALM ) reported fiscal Q3 net income late Tuesday of $10.38 per diluted share, up $3 a year earlier. Three analysts polled by FactSet expected $10.72. Net sales in the three months ended March 1 rose to $1.42 billion from $703.1 million a year earlier. Two analysts expected $1.43 billion....
Trump signs executive orders to boost US coal as power demand rises
Trump signs executive orders to boost US coal as power demand rises
Apr 8, 2025
* US power demand rising from artificial intelligence * Coal's share of power generation less than 20% from 50% in 2000 * Orders to direct coal leasing plans on US lands (Adds comments from Trump, updates to show he signed orders) By Jarrett Renshaw, Timothy Gardner and Trevor Hunnicutt WASHINGTON, April 8 (Reuters) - U.S. President Donald Trump signed executive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved